Recap: INVO Bioscience Q2 Earnings



INVO Bioscience INVO reported its Q2 earnings results on Monday, August 15, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.


INVO Bioscience beat estimated earnings by 4.17%, reporting an EPS of $-0.23 versus an estimate of $-0.24.

Revenue was down $62 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 0.96% drop in the share price the next day.

Here's a look at INVO Bioscience's past performance:


Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate -0.25 -0.22 -0.20 -0.19
EPS Actual -0.23 0.03 -0.24 -0.17
Revenue Estimate 240K 210K 330K 410K
Revenue Actual 162K 3.05M 218K 208K

To track all earnings releases for INVO Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!